Private Capital Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $9K | Sell |
165
-88
| -35% | -$4.8K | 0.01% | 1079 |
|
|
2022
Q1 | $18K | Sell |
253
-44
| -15% | -$3.13K | ﹤0.01% | 1074 |
|
|
2021
Q4 | $29K | Hold |
297
| – | – | 0.01% | 900 |
|
|
2021
Q3 | $26K | Hold |
297
| – | – | 0.01% | 950 |
|
|
2021
Q2 | $24K | Hold |
297
| – | – | 0.01% | 996 |
|
|
2021
Q1 | $28K | Sell |
297
-54
| -15% | -$5.09K | 0.01% | 881 |
|
|
2020
Q4 | $22K | Sell |
351
-835
| -70% | -$52.3K | ﹤0.01% | 1142 |
|
|
2020
Q3 | $71K | Sell |
1,186
-55
| -4% | -$3.29K | 0.01% | 569 |
|
|
2020
Q2 | $87K | Buy |
1,241
+334
| +37% | +$23.4K | 0.02% | 486 |
|
|
2020
Q1 | $41K | Sell |
907
-92
| -9% | -$4.16K | 0.01% | 726 |
|
|
2019
Q4 | $64K | Hold |
999
| – | – | 0.01% | 620 |
|
|
2019
Q3 | $62K | Buy |
999
+109
| +12% | +$6.77K | 0.01% | 674 |
|
|
2019
Q2 | $115K | Buy |
890
+105
| +13% | +$13.6K | 0.03% | 349 |
|
|
2019
Q1 | $62K | Buy |
785
+93
| +13% | +$7.35K | 0.01% | 668 |
|
|
2018
Q4 | $59K | Sell |
692
-172
| -20% | -$14.7K | 0.01% | 584 |
|
|
2018
Q3 | $147K | Sell |
864
-26
| -3% | -$4.42K | 0.03% | 320 |
|
|
2018
Q2 | $114K | Buy |
890
+32
| +4% | +$4.1K | 0.02% | 380 |
|
|
2018
Q1 | $88K | Sell |
858
-745
| -46% | -$76.4K | 0.02% | 454 |
|
|
2017
Q4 | $73 | Buy |
+1,603
| New | +$73 | 0.02% | 530 |
|